AI in Healthcare & Pharma Summit 2026
niting AI experts and healthcare innovators to explore applications transforming drug discovery, clinical trials, diagnostics, and patient outcomes.
niting AI experts and healthcare innovators to explore applications transforming drug discovery, clinical trials, diagnostics, and patient outcomes.
— and 15 more, by name unsung —
Explore how a modular, privacy-first AI framework can close the post-approval commercialization gap and speed equitable patient access. - Identify key post-approval bottlenecks th…
Enterprise-scale AI requires infrastructure that scales with science, not against it. - What defines a modern, production-ready AI stack in pharma? - How are data engineering, MLO…
Personalized care access is becoming table stakes—and AI is the engine behind it. - How are AI tools optimizing prior auth, eligibility, and intake? - What’s the balance between au…
This talk will trace how long-standing, human-centered barriers to innovation adoption—leadership, culture, and self-efficacy—persist today, and identify the unique challenges of c…
Most GenAI initiatives stall because the inputs (SOPs, batch records, clinical/CMC and regulatory files) aren’t clean, structured, or governed. This talk shows how to build validat…
An audience of 44 companies, parsed from the program.
The numbers below are derived from the speakers, sponsors, and exhibitors on this page — cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.
65% of the speakers carry senior titles — C-suite, Founder, VP, or Director-level.
Of 37 on the bill · classified by free-text title
These companies sponsored two or more peer events recently, but aren't on this program. For an organizer, that's a list of warm prospects.